Two new managers join Clondalkin Group Two new managers join Clondalkin Group With a combined experience of 55 years in the packaging sector Luciano Rossetti to become EVP of R&D at Merck Serono Luciano Rossetti to become EVP of R&D at Merck Serono Takes up the position, based in Billerica, MA, US on 21 July Tadahiro Matsumura joins Catalent as Country Leader in Japan Tadahiro Matsumura joins Catalent as Country Leader in Japan Will drive growth through business development in Japan and the surrounding area Oxford BioTherapeutics hires Head of Clinical Development Oxford BioTherapeutics hires Head of Clinical Development Dr Eugen Leo takes the position Mitie Group appoints manufacturing specialist for its Environmental+ business Mitie Group appoints manufacturing specialist for its Environmental+ business Gareth Smallman becomes Director of Manufacturing, Industrial and Specialist Services Biotec Services appoints Martin Lamb as Commercial Director Biotec Services appoints Martin Lamb as Commercial Director He has more than 20 years of industry experience Winners of the Chemical Industry Awards 2014 announced Winners of the Chemical Industry Awards 2014 announced Novartis and GSK are honoured Aesica recruits Business Development Manager Aesica recruits Business Development Manager Nadine Reuter will help drive sales in Germany, Austria and Switzerland Intertek appoints Laboratory Director of Immunochemistry Centre of Excellence Intertek appoints Laboratory Director of Immunochemistry Centre of Excellence Dr Sarah Harris will lead the team in San Diego C4X Discovery appoints Piers Morgan as Chief Executive C4X Discovery appoints Piers Morgan as Chief Executive Succeeds Sam Williams who returns to Non-Executive Director role Solstice Biologics expands management team following achievement of technology milestones Solstice Biologics expands management team following achievement of technology milestones Appoints Lou Tartaglia as President and CEO, while John Borgeson joins as CFO Robbie Stewart and Jen Doody join PCI UK team Robbie Stewart and Jen Doody join PCI UK team New appointments in Business Development and Human Resource Management Oxford BioTherapeutics appoints Chief Scientific Officer Oxford BioTherapeutics appoints Chief Scientific Officer Dr Keith Wilson joins the company from AbbVie ViroCyt strengthens management team ViroCyt strengthens management team Cellular and molecular immunologist joins the company as Chief Technology Officer Spinifex Pharmaceuticals appoints neuroscience expert as Chief Medical Officer Spinifex Pharmaceuticals appoints neuroscience expert as Chief Medical Officer Ronald Marcus joins the Australian-US biotechnology company Biovision announces the winners of the Catalyzer and Investor Conference awards Biovision announces the winners of the Catalyzer and Investor Conference awards This year’s focus was on finance and innovation Biotec Services CEO joins Welsh government advisory panel Biotec Services CEO joins Welsh government advisory panel Aims to maximise the position of Wales in the global life sciences industry Simon Angeldorff stays as CEO at Envirotainer Simon Angeldorff stays as CEO at Envirotainer Following a successful six months as interim CEO at the company Martin Auster joins Ascendis Pharma as Chief Business Officer Martin Auster joins Ascendis Pharma as Chief Business Officer The company uses its TransCon technology to create drugs that address unmet medical needs Seres Health appoints new President and CEO Seres Health appoints new President and CEO Roger Pomerantz was previously Head of Licensing & Acquisitions at Merck & Co Celerion establishes an operation in Singapore Celerion establishes an operation in Singapore To be headed by Chew Lan Chong as Executive Director, Medical Research Kymab makes two management appointments Kymab makes two management appointments Steve Arkinstall joins the company as Chief Scientific Officer and Nigel Clark as Head of Business Development Dieter Weinand to become President of Bayer HealthCare Pharmaceuticals Dieter Weinand to become President of Bayer HealthCare Pharmaceuticals Will take up the role from 1 August Bayer CEO Marijn Dekkers extends contract to the end of 2016 Bayer CEO Marijn Dekkers extends contract to the end of 2016 Werner Baumann appointed as Chief Strategy and Portfolio Officer and Johannes Dietsch to become Chief Financial Officer